SUMMARY Using conventional criteria, a series of 26 infants was selected for intrapartum asphyxia from about 4000 deliveries over one year at a single hospital to assess the efficacy ofa new biochemical method. Tissue damage was estimated from urinary excretion of hypoxanthine, an important and central intermediate in purine metabolism. The overall pattern showed agreement between the grading (by previously accepted methods) of asphyxia in the perinatal period and our new biochemical approach. The association with handicap at one year of age following asphyxia was complex.
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This biochemical technique could be used to exclude postasphyxial damage as a cause of clinical disturbances-and to select a small group (0-1% of all births) who require further investigation for rarer disorders which may also cause long term handicap.
Intrapartum asphyxia is a principal cause of perinatal morbidity and is usually the cause of obstetric intervention.' Present techniques for assessing intrapartum asphyxia are unsatisfactory.23 Asphyxia can be defined at the molecular level: it is a failure of energy supply, sufficient to cause cellular damage. As the energy currency of cells is the purine nucleotide adenosine triphosphate (ATP) the definition is ATP depletion sufficient to cause irreversible or partially reversible cellular damage. ATP is confined to living cells but its depletion can be measured in extracellular fluids when the output of hypoxanthine from tissues into blood, urine, amniotic fluid and cerebrospinal fluid increases. Mechanisms and quantitative associations between concentrations of the central intermediate in purine metabolism, hypoxanthine, and tissue energy supply have been established. '9 The association between ATP depletion and subsequent tissue damage is more difficult to quantify.'°" The transitions between stages of the sequence of events in intrapartum asphyxia can be independently controlled. It is obvious that predisposing causes like the factor(s) causing fetal growth retardation need not be associated with asphyxia ifcompensatory mechanisms like increased haemoglobin synthesis, and more Accepted for publication 16 September 1987 acutely, fetal tachycardia are adequate to ensure oxygen delivery. If cord occlusion has occurred then decompensation with asphyxia (fetal ATP depletion) might occur. ATP concentrations may recover, especially if there is early obstetric intervention. If ATP depletion is severe and prolonged tissue damage may occur. The infant may then die or may completely recover from the tissue damage; more rarely, some permanent defect may be sustained.
Unexpectedly, there is a close positive correlation between neurological damage, assessed clinically in the neonatal period, and persistently excessive hypoxanthine excretion occurring 24 hours after ATP depletion and lasting for several days'2; this presumably reflects the renal damage known to occur after asphyxia. This persistent change must have a different basis to the increased hypoxanthine output occurring in the first six to 12 hours after ATP depletion. Hypoxanthine excretion can be measured as a hypoxanthine:creatinine concentration ratio,'3 and an incomplete urine sample using a non-invasive method can therefore be used to estimate quantitatively tissue damage after ATP depletion.
As the application of published findings would seem to solve the widely recognised problem ofthe quantitation of postasphyxial damage in brain and kidney' 14 These studies were conducted with the approval of the ethical committee of the Simpson Memorial Maternity Pavillion.
Results
After the results were exchanged and grouped (table 1) it was clear that there was overall agreement (tables 2 and 3) with some interesting exceptions (tables 4 and 5).
The previously accepted clinical and biochemical assessments of the severity of asphyxia in the newborn and their subsequent development at the age of I year were grouped with our new biochemical estimates of the damage after ATP depletion from hypoxanthine excretion. Table 2 shows that 11 infants were normal by both clinical and our biochemical method with normal development at I year of age. Table 3 shows that six infants showed moderate or severe asphyxia by existing criteria and by our biochemical method. One of these infants died before follow up and two showed some abnormalities in their development; three, however, showed normal development. It was expected that a sensitive quantitative variable would show abnormalities in some infants judged by existing means to be only mildly asphyxiated. This is the pattern in table 4 which shows that cases 18 and 19 were clearly biochemically abnormal with consistent results for the hypoxanthine creatinine concentration ratios and total excretions of both hypoxanthine and xanthine. Cases 20 and 21 had normal hypoxanthine: creatinine concentration ratios and were clinically only mildly asphyxiated with normal development. In 17 of26 (69%) infants there was agreement between the two approaches: to this could be added three other preterm (weighing < 1500 g) infants not considered in detail and all of whom had severe asphyxia by previously accepted criteria.
Our results confirm that a quantitative method of estimating tissue damage after ATP depletion is available; and we have extended previous work.'2 In this study we used a more careful double blind system at two different sites with developmental assessment at I year of age. In a concurrent study we also showed that excessive prolonged hypoxanthine excretion 
Severe tissue damage quantitatively similar to that which caused the death of one patient was also associated with only slight doubt about the later development of another patient (case 15). Such variations in outcome and extensive recovery have previously been recognised."'20 Neonatal mortality and stillbirth rates have fallen over the past 30 years, but the incidence of cerebral palsy is virtually unchanged. We did not therefore expect and did not find a good correlation between our results for 1 year old babies and the perinatal assessments.
Parental attitudes and stimulation are strong influences on behavioural and intellectual outcome2 22 and can affect growth.23 We therefore noted the father's occupation as an indirect assessment of environmental quality and genetic endowment.
The only clear discrepancy between a diagnosis by existing methods and our biochemical method was in one patient (case 26) in whom the hypoxanthine: creatinine ratio was normal but in whom the total hypoxanthine and xanthine excretion were high (figure) . The creatinine concentration may have been falsely high due to interference from the colour reaction used.
Previous The low hypoxanthine output from infants treated with special care has also been noted from the Northwick Park Hospital special care baby unit. '2 Both sets of our results were lower than estimates based on spectrophotometric methods of about 40 nmol/hour/kg body weight. 25 We identified two infants (cases 18 and 19) in whom oxypurine excretion showed in greater tissue damage than previously accepted estimates. Hypoxanthine excretion seems to be a sensitive measure of tissue damage after ATP depletion because the hypoxanthine:creatinine ratios after moderate or severe asphyxia (table 3) were four to eight times the ratios after mild asphxia (table 2) . In a recent study of renal damage after perinatal asphyxia urinary N-acetyl-,BDglucosaminidase, a sensitive marker of renal tubular damage, only increased about fourfold. Measurements related to glomerular filtration rate only doubled or halved. 26 The biochemical basis of our method is ill understood in contrast to the clear understanding of the use of hypoxanthine output to measure acute ATP depletion. Persistent excessive hypoxanthine output may be linked to the failure of damaged tissues to maintain their total adenine nucleotide concentrations.'"
Having established and confirmed in the present study the validity of the biochemical method,'2 the next task is to examine its possible role(s) in clinical practice. Widespread routine use seems inappropriate in infants who have had a clear cause of asphyxia, like a prolapsed cord, or pronounced effects of asphyxia like fits. We defined a small group of about 0-1% of all births (tables 5 and 6) in whom further detailed investigation may be justifiable. Cases 23 and 25 who showed some developmental abnormality (table 5) may have some additional reason for such persistent problems. Our results are consistent with evidence from less direct and less sensitive methods, suggesting that about half the children with cerebral palsy may not have had intrapartum asphyxia.'927 Furthermore, in patients initially diagnosed as having the effects of intrapartum asphyxia we have already retrospectively found patients with congenital adrenocortical hypoplasia,28 septo-optic dysplasia, and the Lesch Nyhan syndrome.
Our results are consistent with epidemiology which shows that many cases of cerebral palsy are probably not due to cerebral asphyxia as was thought previously; in 1987 Stanley concluded that the use of cerebral palsy to evaluate perinatal practice should be questioned. 29 Our results for hypoxanthine excretion agree with previously used criteria with a few interesting exceptions. By sensitively measuring asphyxial damage, which is common, those few sick infants who do not have sufficient asphyxial damage to account for their clinical findings, especially developmental delay, and who therefore require further investigation for rarer disorders like inherited metabolic diseases, congenital defects with and without chromosomal anomalies, 
